Letter | Published:

‘Viractin’ : a Prophylactic Agent against Upper Respiratory Infections

Nature volume 204, pages 788789 (21 November 1964) | Download Citation

Subjects

Abstract

‘VIRACTIN’ is the name we are proposing for the active principle in the mycelium of Streptomyces griseus cultures which produce actidione1,2, and which we have found to prevent selectively upper respiratory infections in man. The activity of viractin was first noted in 1946 while one of us (B. E. L.) was isolating, crystallizing, and characterizing actidione. It was observed then that the people working with the actidione process were not susceptible to upper respiratory infections.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , and , J. Amer. Chem. Soc., 69, 474 (1947).

  2. 2.

    , and , J. Amer. Chem. Soc., 70, 1223 (1948).

  3. 3.

    , , , , , , , , , and , Science, 144, 862 (1964).

Download references

Author information

Affiliations

  1. 4718 Kenmore Avenue, Alexandria, Virginia.

    • BYRON E. LEACH
  2. Gulfport Division, Veterans Administration Center, Biloxi, Mississippi.

    • PEARL E. HACKMAN
  3. Department of Psychiatry and Neurology, Tulane University, School of Medicine, New Orleans, Louisiana.

    • LAWRENCE W. BYERS

Authors

  1. Search for BYRON E. LEACH in:

  2. Search for PEARL E. HACKMAN in:

  3. Search for LAWRENCE W. BYERS in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/204788a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.